GUANGZHOU, China, Aug. 8 /Xinhua-EMWNews/ -- China Medicine

Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"),

a leading developer and distributor of prescription and over the counter

pharmaceuticals, traditional Chinese medicines (TCM), nutritional and

dietary supplements, and medical devices and medical formulations, today

announced that it will conduct a conference call at 10:00 a.m. Eastern Time

on Wednesday, August 13, 2008 to discuss its second quarter 2008 results.



    Joining Mr. Shensan Yang, Chairman and Chief Executive Officer of China

Medicine Corporation, will be Ms. Huizhen Yu, Chief Financial Officer. The

Company plans to make an earnings announcement prior to the call.



    To participate in the live conference call, please dial the following

number five to ten minutes prior to the scheduled conference call time:

888-482-0024. International callers should dial 617-801-9702, Conference

Passcode: 38093968.



    If you are unable to participate in the call at this time, a replay

will be available for 14 days starting on August 13, at 12:00 p.m. Eastern

Time. To access the replay, dial 888-286-8010, international callers dial

617-801-6888, and enter the passcode of 73037488

    About China Medicine Corporation



    China Medicine Corporation is a leading pharmaceutical company which

discovers, develops, and distributes over 2,200 pharmaceutical products in

China including prescription and over the counter ("OTC") drugs,

traditional Chinese medicine ("TCM") products, herbs and dietary

supplements. The Company distributes the products to wholesale distributors

in 28 provinces, over 300 hospitals, 500 medicine companies, and 1,788 drug

stores throughout China. The Company actively develops a number of

proprietary products for many uses including oncology, high blood pressure

and the removal of toxins from food and animal feeds. For more information

visit the Company's website at http://www.chinamedicinecorp.com .



    Cautionary Statement



    This press release contains forward-looking statements concerning the

Company's business, products and financial results. The Company's actual

results may differ materially from those anticipated in the forward-looking

statements depending on a number of risk factors including, but not limited

to, the following: general economic and business conditions, development,

shipment, market acceptance, additional competition from existing and new

competitors, changes in technology, and various other factors beyond the

Company's control. All forward-looking statements are expressly qualified

in their entirety by this Cautionary Statement and the risk factors

detailed in the Company's reports filed with the Securities and Exchange

Commission. China Medicine Corporation undertakes no duty to revise or

update any forward-looking statements to reflect events or circumstances

after the date of this release.






    For more information, please contact:



    Company Contact:

     Ms. Huizhen Yu

     Chief Financial Officer

     China Medicine Corporation

     Tel:   +1-732-438-8866

     Email: [email protected]



    Investor Relations Contact:

     Mr. Crocker Coulson

     President

     CCG Investor Relations

     Tel:   +1-646-213-1915 (NY Office)

     Email: [email protected]